JP2023500574A5 - - Google Patents
Info
- Publication number
- JP2023500574A5 JP2023500574A5 JP2022520769A JP2022520769A JP2023500574A5 JP 2023500574 A5 JP2023500574 A5 JP 2023500574A5 JP 2022520769 A JP2022520769 A JP 2022520769A JP 2022520769 A JP2022520769 A JP 2022520769A JP 2023500574 A5 JP2023500574 A5 JP 2023500574A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- amino acid
- chimeric molecule
- molecule according
- tmmp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962925115P | 2019-10-23 | 2019-10-23 | |
| US62/925,115 | 2019-10-23 | ||
| PCT/US2020/056908 WO2021081239A1 (en) | 2019-10-23 | 2020-10-22 | T-cell modulatory chimeric molecules and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500574A JP2023500574A (ja) | 2023-01-10 |
| JP2023500574A5 true JP2023500574A5 (cg-RX-API-DMAC7.html) | 2023-10-25 |
Family
ID=75620861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520769A Pending JP2023500574A (ja) | 2019-10-23 | 2020-10-22 | T細胞調節性キメラ分子及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230055644A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4048689A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023500574A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114599674A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020370292A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3146917A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL290298A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021081239A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201808552XA (en) * | 2016-05-18 | 2018-10-30 | Cue Biopharma Inc | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN110325205B (zh) | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| KR20240005989A (ko) | 2017-03-15 | 2024-01-12 | 큐 바이오파마, 인크. | 면역 반응을 조절하는 방법 |
| WO2019051127A1 (en) | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| EP3897746A4 (en) * | 2018-12-19 | 2022-10-26 | Cue Biopharma, Inc. | MULTIMERIC T LYMPHOCYTE MODULATING POLYPEPTIDES AND METHODS OF USE THEREOF |
| IL296209A (en) | 2020-05-12 | 2022-11-01 | Cue Biopharma Inc | Multimeric t-cell modulatory polypeptides and methods of using them |
| JP2023541366A (ja) | 2020-09-09 | 2023-10-02 | キュー バイオファーマ, インコーポレイテッド | 1型真性糖尿病(t1d)を治療するためのmhcクラスii t細胞調節多量体ポリペプチド及びその使用方法 |
| EP4504802A4 (en) * | 2022-04-07 | 2026-03-25 | Cue Biopharma Inc | IMMUNE CELL BINDING POLYPEPTIDES |
| GB202205771D0 (en) * | 2022-04-20 | 2022-06-01 | Replay Holdings Llc | Methods and compositions for cellular therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2178896A1 (en) * | 2007-07-31 | 2010-04-28 | The Johns Hopkins University | Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| CN122399016A (zh) * | 2014-03-15 | 2026-07-17 | 诺华股份有限公司 | 使用嵌合抗原受体治疗癌症 |
| JP6652932B2 (ja) * | 2014-06-18 | 2020-02-26 | アルバート アインシュタイン カレッジ オブ メディシン | synTacポリペプチド及びその使用 |
| CN110325205B (zh) * | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| KR20240005989A (ko) * | 2017-03-15 | 2024-01-12 | 큐 바이오파마, 인크. | 면역 반응을 조절하는 방법 |
| WO2019051127A1 (en) * | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
-
2020
- 2020-10-22 CN CN202080064663.3A patent/CN114599674A/zh not_active Withdrawn
- 2020-10-22 AU AU2020370292A patent/AU2020370292A1/en not_active Abandoned
- 2020-10-22 CA CA3146917A patent/CA3146917A1/en active Pending
- 2020-10-22 EP EP20878131.0A patent/EP4048689A4/en not_active Withdrawn
- 2020-10-22 JP JP2022520769A patent/JP2023500574A/ja active Pending
- 2020-10-22 WO PCT/US2020/056908 patent/WO2021081239A1/en not_active Ceased
-
2022
- 2022-02-02 IL IL290298A patent/IL290298A/en unknown
- 2022-02-23 US US17/678,748 patent/US20230055644A1/en not_active Abandoned
-
2025
- 2025-09-12 US US19/327,171 patent/US20260070959A1/en active Pending